dihexa retracted paper controversy

dihexa retracted paper controversy This morning, @novartis announced that del-brax met the primary and key secondary endpoints in the biomarker cohort of the Phase 1/2 FORTITUDE study. The results showed reductions in biomarkers associated with DUX4 Alzheimer's Paper Authors "Admit Falsification";

Name: dihexa retracted paper controversy This morning, @novartis announced that del-brax met the primary and key secondary endpoints in the biomarker cohort of the Phase 1/2 FORTITUDE study. The results showed reductions in biomarkers associated with DUX4 Alzheimer's Paper Authors "Admit Falsification";
Brand: www.aliseon.com
SKU: 23329453091
Price: 21.19 USD
Availability: InStock
Rating: 4.5121 (14 reviews)

SKU: 23329453091

4.5

USD21.19 USD54.19

Pay in 4 interest-free payments of $5.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

However, elevated levels may indicate underlying conditions such as liver disease, haematological disorders, or kidney impairment that require medical investigation and management